{
    "clinical_study": {
        "@rank": "136343", 
        "acronym": "MAPA", 
        "arm_group": [
            {
                "arm_group_label": "Subclinical atherosclerosis", 
                "description": "In vitro estimation of individual reactivity of monocytes in study participants with asymptomatic atherosclerotic plaques found in carotid arteries by ultrasound examination"
            }, 
            {
                "arm_group_label": "Healthy subjects", 
                "description": "In vitro estimation of individual reactivity of monocytes in study participants without ultrasound signs of subclinical carotid atherosclerosis"
            }, 
            {
                "arm_group_label": "Diffuse intimal thickening", 
                "description": "In vitro estimation of individual reactivity of monocytes in study participants with diffuse intima-media thickening of carotid arteries found at ultrasound examination"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood taken with anticoagulants for immediate monocyte isolation to be seeded in cell\n      culture, and for preparation of plasma samples to be frozen for lipid analysis."
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The study of proinflammatory and anti-inflammatory cytokines and chemokines expression\n      profiles in human monocytes to identify new effective biomarkers that have the best\n      diagnostic potential in asymptomatic atherosclerosis."
        }, 
        "brief_title": "Monocyte Activation in Preclinical Atherosclerosis", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Atherosclerosis", 
        "condition_browse": {
            "mesh_term": "Atherosclerosis"
        }, 
        "detailed_description": {
            "textblock": "This project is the first step in creating a method for assessing an individual activity of\n      macrophages. The problems addressed in the project are socially significant because of the\n      high incidence of life-threatening diseases and their effects in the population. The method\n      of evaluation of monocyte-macrophages activity in human blood will be based on the analysis\n      of expression of cytokines and chemokines - markers of inflammatory and anti-inflammatory\n      activity of macrophages. The most informative panel of cytokines and chemokines obtained\n      during the project can be further used to create effective diagnostic tests."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  men and women aged 40 to 74 years\n\n          -  arterial normotension or mild arterial hypertension (systolic blood pressure <160 mm\n             Hg, diastolic blood pressure <90 mm Hg)\n\n          -  absence of chronic diseases demanding permanent drug administration (more than 2\n             month per year)\n\n        Exclusion Criteria:\n\n          -  personal history of transient ischemic attacks\n\n          -  personal history of chronic diseases demanding permanent drug administration (more\n             than 2 month per year)\n\n          -  personal history of life-threatening diseases\n\n          -  indications for surgical treatment of atherosclerotic lesions localized in the\n             extracranial brachiocephalic system"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "79 Years", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The inclusion of healthy individuals, of apparently healthy persons with a predisposition\n        to atherosclerosis, and subjects with subclinical atherosclerosis, according to the\n        results of ultrasonographic examination of carotids, to achieve 80% statistical power (up\n        to 50 study participants per group).\n\n        Conducting experiments on obtaining the individual cultures of blood monocytes and\n        stimulation of cells by proinflammatory and anti-inflammatory stimuli"
            }
        }, 
        "enrollment": {
            "#text": "170", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02126280", 
            "org_study_id": "IAR-MAPA"
        }, 
        "intervention": {
            "arm_group_label": [
                "Subclinical atherosclerosis", 
                "Healthy subjects", 
                "Diffuse intimal thickening"
            ], 
            "description": "Technique for isolation/separation of monocytes with culture purity more than 95 % CD14-positive cells according to flow cytometry, the share of viable cells at least 98% by trypan blue vital staining, capable of producing TNFa at concentration of at least 50 pg/ml when stimulated with 100 ng/ml IFN-gamma, and CCL18 at concentration at least 30 pg/ml when stimulated with 10 ng/ml interleukin.", 
            "intervention_name": "In vitro estimation of individual reactivity of monocytes", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "proinflammatory cytokines", 
            "anti-inflammatory cytokines", 
            "human monocytes", 
            "activation", 
            "biomarkers", 
            "asymptomatic atherosclerosis"
        ], 
        "lastchanged_date": "April 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Moscow", 
                    "country": "Russian Federation", 
                    "zip": "121609"
                }, 
                "name": "Institute for Atherosclerosis Research"
            }
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_groups": "3", 
        "official_title": "Cross-sectional Clinical Study of the Individual Profile of Activation of Circulating Blood Monocytes in Subjects With Preclinical Atherosclerosis.", 
        "overall_official": {
            "affiliation": "Institute for Atherosclerosis Research", 
            "last_name": "Alexander N Orekhov, PhD, DSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Russia: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Technique for isolation/separation of monocytes with culture purity more than 95 % CD14-positive cells according to flow cytometry, the share of viable cells at least 98% by trypan blue vital staining, capable of producing TNFa at concentration of at least 50 pg/ml when stimulated with 100 ng/ml IFN-gamma, and CCL18 at concentration at least 30 pg/ml when stimulated with 10 ng/ml interleukin.", 
            "measure": "Development and optimization of the method of monocyte-macrophage isolation.", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1 years"
        }, 
        "reference": [
            {
                "PMID": "23438959", 
                "citation": "Gratchev A, Ovsiy I, Manousaridis I, Riabov V, Orekhov A, Kzhyshkowska J. Novel monocyte biomarkers of atherogenic conditions. Curr Pharm Des. 2013;19(33):5859-64. Review."
            }, 
            {
                "PMID": "22325375", 
                "citation": "Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology. 2012 May;217(5):476-82. doi: 10.1016/j.imbio.2012.01.008. Epub 2012 Jan 13. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02126280"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Creating a collection of samples of the culture medium during cell stimulation into pro-inflammatory or anti-inflammatory phenotype.\nDefinition of individual profiles of cell activation by the production of proinflammatory and anti-inflammatory cytokines and chemokines (C5a, IL-4, IL-32 alpha, CD40 ligand, IL-5, CXCL10, G-CSF, IL-6, CXCL11/I-TAC, GM-CSF , IL-8, CCL2, CXCL1, IL-10, MIF, CCL1, IL-12 p70, CCL3, ICAM-1, IL-13, CCL4, IFN-gamma, IL-16, CCL5, IL-1 alpha, IL -17, CXCL12, IL-1 beta, IL-17E, Serpin E1, IL-1ra, TNF-alpha, IL-2, IL-27, and TREM-1).\nDatabase generation on individual reactivity of monocytes-macrophages from healthy donors, individuals predisposed to atherosclerosis, and patients with asymptomatic atherosclerosis.\nCreating a collection of samples. Determination of concentrations of pro-inflammatory and anti-inflammatory markers.", 
            "measure": "Sample processing and parameter measurements.", 
            "safety_issue": "Yes", 
            "time_frame": "up to 1 years"
        }, 
        "source": "Institute for Atherosclerosis Research, Russia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute for Atherosclerosis Research, Russia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}